manufacturing problems — e.g. “Disruption of the manufacture of the drug.” (Canada)
causes not stated by the regulator
Drugs in the same class as Ranitidine
Same-class context from the WHO ATC classification only — not a clinical substitution recommendation, not reviewed by a pharmacist, and not dose-equivalent. Form, strength, route and indication may differ. Confirm any switch with a prescriber.
Yes. As of the latest regulator updates, Ranitidine has 7 active shortage notices across 1 country (Canada). Status is refreshed daily from official regulatory sources.
Why is Ranitidine in shortage?
Regulators attribute the current Ranitidine shortages to supply-chain disruption, manufacturing problems, causes not stated by the regulator. The exact cause varies by country and product — each notice on this page links to the official source.
When will the Ranitidine shortage be resolved?
Regulator-estimated resolution dates currently range from 30 Dec 2022 to 30 Dec 2022, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.
What are the alternatives to Ranitidine?
Mederti lists 2 drugs in the same WHO ATC class as Ranitidine (see above). These are classification context only — not clinically reviewed substitutes. Always confirm any switch with a pharmacist or prescriber and your national guidance.
Where does this Ranitidine shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.
Data on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.